Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)

Journal of Cancer Therapy
doi 10.4236/jct.2018.911072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Journal of Oncology
Oncology
2009English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Baby Steps: Pregnancy Outcomes After Human Epidermal Growth Factor Receptor 2-Targeted Therapy

Cancer
Cancer ResearchOncology
2018English

Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy

Oncology Reports
MedicineCancer ResearchOncology
2008English

ErbB-2 Blockade and Prenyltransferase Inhibition Alter Epidermal Growth Factor and Epidermal Growth Factor Receptor Trafficking and Enhance 111In-Dtpa-hEGF Auger Electron Radiation Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues

Korean Journal of Clinical Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy